Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults
2 other identifiers
interventional
84
1 country
1
Brief Summary
By 2015 half of the people living with HIV infection in the U.S. are estimated be over the age of 50, and this cohort of patients with well-controlled plasma viremia is aging at a more rapid pace than their non-HIV peers. Long-term chronic inflammation plays a critical role in premature aging in HIV-infected adults. Markers associated with chronic inflammation, including IL-6, CRP, sCD14 and d-dimer, have not only been shown to be present at higher levels in HIV-infected adults, but are also correlated to a wide variety of morbidities and mortality. The goal of this project is to determine the impact of two different interventions -- Mindfulness-Based Stress Reduction (MBSR) and Health Enhancement Program (HEP) -- on reducing biological markers associated with chronic inflammation in HIV-infected adults with an undetectable HIV viral load. In order to achieve this goal, a pilot RCT with 120 subjects over 50 years old who are on anti-retroviral therapy (ART) will be conducted with the following specific aims: 1) to assess the effect of MBSR and/or HEP on biomarkers of chronic inflammation (IL-6, CRP, sCD14, d-dimer), and, 2) to explore whether changes in psychological well-being (anxiety, depression, fatigue, cognitive functioning) mediate the impact on chronic inflammation. Subjects will be randomized to participation in a group MBSR course or to the HEP group both of which consist of 8 weekly sessions followed by 6 monthly booster sessions. Three time points will be measured: baseline, 8 weeks (immediately after completion of weekly intervention), and 6-months post-completion of weekly intervention. Mixed linear and structural equation model will be used to test the study hypotheses. The proposed study is innovative in that it is the first to explore the impact of a complementary mind-body intervention on chronic inflammation in HIV-infected adults. Given that the consequences of early aging in this cohort will be a burden on the health care system as well as a medical, social and psychological burden on those living with HIV, the study has the potential to have a major public health impact.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2015
CompletedFirst Posted
Study publicly available on registry
December 10, 2015
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2017
CompletedResults Posted
Study results publicly available
May 9, 2022
CompletedMay 9, 2022
April 1, 2022
1.8 years
December 8, 2015
March 15, 2022
April 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Interleukin 6 (IL-6) Biological Markers
Interleukin 6 (IL-6) biological markers at 8 weeks and 6 months as compared to baseline.
Baseline, 8 weeks post intervention, and 6 months post intervention
Secondary Outcomes (5)
PROMIS - Anxiety
Baseline, 8 weeks post intervention, and 6 months post intervention
PROMIS - Fatigue
Baseline, 8 weeks post intervention, and 6 months post intervention
BDI-II
Baseline, 8 weeks post intervention, and 6 months post intervention
FFMQ
Baseline, 8 weeks post intervention, and 6 months post intervention
Retention Rates
6 months
Study Arms (2)
MBSR Course
EXPERIMENTALMindfulness-Based Stress Reduction Course (MBSR) consisting of 8 weekly sessions, 2.5 hours each, and a 5 hour silent retreat during the 6th week of the program.
HEP Course
EXPERIMENTALHealth Enhancement Program (HEP) consisting of 8 weekly sessions, 2.5 hours each, and 1.5 hour monthly educational sessions after the 8 week intervention.
Interventions
Formal mindfulness meditation methods taught in the MBSR course include: Body Scan Meditation (a supine meditation), Gentle Hatha Yoga (practiced with mindful awareness of the body), Sitting Meditation (mindfulness of breath, body, feelings, thoughts, and emotions), and Walking Meditation. Informal Mindfulness Meditation Practices (mindfulness in everyday life) include: 1) awareness of pleasant and unpleasant events, and, 2) deliberate awareness of routine activities and events such as eating, weather, walking, and interpersonal communication. Daily home assignments include a minimum of 30 minutes daily formal mindfulness practices and 5-15 minutes informal practice, 6 days per week for the entire duration of the course. Course sessions will consist of discussions oriented around weekly homework assignments, including an exploration of obstacles, and development of self-regulatory skills and capacities.
HEP is an active control that matches MBSR in non-specific factors, such as the amount of time participants interact, but does not include mindfulness practice as an active component. HEP instructors will be selected from experts in the areas covered: music, nutrition education, and, functional movement. The study's RC will coordinate HEP sessions and monitor attendance. Following the 8-week HEP protocol, subjects will meet monthly in 1.5-hour educational sessions to match the booster sessions of MBSR participants.
Eligibility Criteria
You may qualify if:
- HIV-infected for 5 or more years
- On ART for 5 or more years
- HIV viral load consistently \<48 copies/mL for the last year
- No anticipated changes in ART by provider or patient
- Fluency in the English language
- Age 45 years or older
- Willingness to complete the entire MBSR or HEP interventions
You may not qualify if:
- Having participated in an MBSR course in the past
- Current meditation and/or yoga practice
- Began psychiatric medications in the past 2 months or plans to discontinue psychiatric medications
- Currently receiving steroids or immunosuppressant drugs
- Women who are pregnant or plan to become pregnant in the next year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jeffrey Weiss, PhD, MS
- Organization
- Icahn School of Medicine at Mount Sinai
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey Weiss, PhD
Icahn School of Medicine at Mount Sinai
- PRINCIPAL INVESTIGATOR
Peter Barbosa, PhD
New York College of Podiatric Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 8, 2015
First Posted
December 10, 2015
Study Start
March 1, 2016
Primary Completion
December 18, 2017
Study Completion
December 18, 2017
Last Updated
May 9, 2022
Results First Posted
May 9, 2022
Record last verified: 2022-04